Prosecution Insights
Last updated: November 20, 2026
Application No. 18/750,857

APPARATUS AND METHODS FOR GAS VERIFICATION

Non-Final OA §103
Filed
Jun 21, 2024
Priority
Oct 13, 2020 — provisional 63/090,887 +1 more
Examiner
KOLB, NATHANIEL J
Art Unit
2855
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Alcon Inc.
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
6m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
396 granted / 634 resolved
-5.5% vs TC avg
Strong +35% interview lift
Without
With
+34.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
33 currently pending
Career history
674
Total Applications
across all art units

Statute-Specific Performance

§101
3.0%
-37.0% vs TC avg
§103
45.6%
+5.6% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
30.3%
-9.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 634 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Summary Claims 1-7 are pending. Claims 6 and 7 are withdrawn due to an Election of Species. Claims 1-5 are rejected herein. This is a First Action on the Merits. Election/Restrictions This application contains claims directed to the following patentably distinct species: Species 1- using temperature and resistance/impedance to detect gas concentration and Species 2- using an oscillator and electron excitation to detect gas concentration. The species are independent or distinct because they use completely different physical principles and sensors to operate and will therefore require completely different searches. In addition, these species are not obvious variants of each other based on the current record. Applicant is required under 35 U.S.C. 121 to elect a single disclosed species, or a single grouping of patentably indistinct species, for prosecution on the merits to which the claims shall be restricted if no generic claim is finally held to be allowable. Currently, claim 1 is generic. There is a serious search and/or examination burden for the patentably distinct species as set forth above because at least the following reason(s) apply: The inventions of the different species have different classifications and will require different classification and text searching. Applicant is advised that the reply to this requirement to be complete must include (i) an election of a species to be examined even though the requirement may be traversed (37 CFR 1.143) and (ii) identification of the claims encompassing the elected species or grouping of patentably indistinct species, including any claims subsequently added. An argument that a claim is allowable or that all claims are generic is considered nonresponsive unless accompanied by an election. The election may be made with or without traverse. To preserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the election of species requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are added after the election, applicant must indicate which of these claims are readable on the elected species or grouping of patentably indistinct species. Should applicant traverse on the ground that the species, or groupings of patentably indistinct species from which election is required, are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing them to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the species unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other species. Upon the allowance of a generic claim, applicant will be entitled to consideration of claims to additional species which depend from or otherwise require all the limitations of an allowable generic claim as provided by 37 CFR 1.141. During a telephone conversation with Mitchell Walsh on 13 Oct 2026 a provisional election was made without traverse to prosecute the invention of Species 1, claims 1-5. Affirmation of this election must be made by applicant in replying to this Office action. Claims 6 and 7 withdrawn from further consideration by the examiner, 37 CFR 1.142(b), as being drawn to a non-elected invention. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-4 is/are rejected under 35 U.S.C. 103 as being unpatentable over COMMANDER et al. (US 20180116869) in view of WYETH et al. (US 2019/0262526) and KERTSER (US 20190060591). Regarding claims 1-4: COMMANDER discloses: A method, comprising: preparing a volume of mixed gas (para. 27, 37), and introducing the gas into a patient's eye (para. 27; FIG. 1). COMMANDER does not disclose dividing the fluid into two portions and testing one of the portions. WYETH, however, does teach that when injecting fluids into a patient (718 in FIG. 17A), the volume of mixed fluid can be divided into a first portion and a second portion (“a sample of the mixing container is withdrawn and tested at 473” in para. 206) to test that the first portion/sample has the correct concentration (para. 206); introducing the first portion into a chamber (in conductivity sensor 764 in FIG. 17A; para. 206), the chamber housing an element (conductivity sensing element; para. 206); determining a change in a physical characteristic (“The concentration of electrolyte concentrate can be determined by the controller 739 by the conductivity measurement” in para. 206) of the element that changes in response to temperature (Conductivity measurement is temperature dependent as set forth in para. 171.) or electron excitation, the physical characteristic indicative of a parameter of the first portion (Concentration in para. 206); determining that the parameter satisfies a predetermined value (para. 206). One skilled in the art at the time the application was effectively filed would be motivated to test the concentration of the injected fluid of COMMANDER with a sensor as taught by WYETH to ensure that the correct amount of agent is injected into the patient (para. 118 of WYETH). Please note that the temperature-dependent conductivity measurement of WYETH is performed on a liquid not a gas. It is, however, known to test the conductivity of a gas as taught by KERTSER, which teaches a chamber (132 in FIG. 1) that receives a gas sample (TARGET SAMPLE in FIG. 1; para. 52) and measures thermal conductivity (para. 52) while heating the sample (para. 52) and measuring the temperature (para. 43) to determine a concentration of a constituent of the gas (para. 52). WYETH also teaches that the element is an electrical element configured to heat a gas, measure a temperature of a gas, or a combination thereof (heating element; temperature sensor; MEMS chip; para. 6-9), thus meeting the limitations of claim 2. Because the device is implemented electronically (para. 6-9), the output signal of the temperature sensors will be based on a change in resistance of the sensing element, thus meeting the limitations of claims 3 and 4. One skilled in the art at the time the application was effectively filed would be motivated to use gas concentration sensor of KERTSER to measure the concentration of a portion of a gas administered to a patient’s eye (para. 27 of COMMANDER) to ensure that the correct amount of agent is injected into the patient (para. 118 of WYETH). Claim(s) 5 is/are rejected under 35 U.S.C. 103 as being unpatentable over COMMANDER, WYETH, and KERTSER in view of ROBERTSON et al. (US 20140367092). Regarding claim 5: The MEMS temperature sensor cited in the rejection of claims 2 and 3 does not teach using an AC voltage and measuring impedance. ROBERTSON teaches that it is known to use both AC and DC measurements (Para. 149; 135-136) in their invention that measures temperature (para. 49; 58) of a gas (para. 89). It would be obvious to one skilled in the art at the time the application was effectively filed to use any known temperature sensor to produce the temperature data of the invention of COMMANDER as modified by WYETH and KERTSER because the data sought is the temperature of the medium. Therefore this is an instance of “Simple Substitution of One Known Element for Another to Obtain Predictable Results” (see MPEP 2143 B). In the present case the known elements are different types of temperature sensors, and the predictable results are that the temperature is measured. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NATHANIEL J KOLB whose telephone number is (571)270-7601. The examiner can normally be reached M-F 9-5 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Peter Macchiarolo can be reached at 571-272-2375. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NATHANIEL J KOLB/Examiner, Art Unit 2855
Read full office action

Prosecution Timeline

Jun 21, 2024
Application Filed
Nov 09, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12800421
LEAK DETECTOR WITH CLAMP FOR ENCLOSING A SECTION OF PIPE
2y 0m to grant Granted Nov 17, 2026
Patent 12791509
GAS DETECTION METHOD, INFORMATION PROCESSING APPARATUS, METHOD OF DIAGNOSING A PLANT, AND PLANT DIAGNOSING APPARATUS
3y 1m to grant Granted Nov 10, 2026
Patent 12791421
Light fixture with self-test ability of sealing
2y 5m to grant Granted Nov 10, 2026
Patent 12782170
AIRCRAFT SENSOR WITH VENTED BORES IN A STRUT
3y 1m to grant Granted Nov 03, 2026
Patent 12782253
CYLINDRICAL BATTERY CELL IMPACT TEST METHODS AND CYLINDRICAL BATTERY CELL IMPACT TEST APPARATUSES THEREFOR
2y 1m to grant Granted Nov 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
97%
With Interview (+34.6%)
2y 11m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 634 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month